Menu
Back to Journals » OncoTargets and Therapy » Volume 15
Corrigendum
RANKL/RANK Pathway Abrogates Cetuximab Sensitivity in Gastric Cancer Cells via Activation of EGFR and c-Src [Corrigendum]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,007 | Dovepress* | 3,977+ | 248 | 4,225 | |
| PubMed Central* | 30 | 20 | 50 | ||
| Totals | 4,007 | 268 | 4,275 | ||
| *Since 13 May 2022 | |||||
View citations on PubMed Central and Google Scholar